Health Condition 1: C34- Malignant neoplasm of bronchus andlung
Conditions
Interventions
Control Intervention1: nil: nil
Sponsors
Dr. Flavia Lyn Jashan
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with histologically confirmed lung carcinoma. 2.Patients scheduled for radiotherapy with a radical intent using the VMAT technique. 3.Age 18 years or older. 4.Adequate baseline pulmonary function tests for safe participation
Exclusion criteria
Exclusion criteria: Lung cancer patients treated with palliative radiotherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the proportion of patients developing acute radiation pneumonitis as defined by CTCAE v5.0Timepoint: weekly during radiotherapy treatment and at treatment completion | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the level of change in quality of life using the EORTC QLQ-LC13 questionnaire.Timepoint: baseline,6 weeks,3months;To assess the proportion of patients achieving complete response after 6 months with repeat CECT/PET-CTTimepoint: 6 months;To assess the proportion of patients developing acute radiation esophagitis as defined by CTCAE v5.0Timepoint: 1 week,2 week,3 week,4 week,5 week,6 week;To report the dose constraints achieved with VMAT techniqueTimepoint: 6 weeks | — |
Countries
India
Contacts
Public ContactDr Ambedkar Yadala
JIPMER
Outcome results
None listed